ERBB2 and breast cancer: It was also reported that sensitivity of breast cancer cells to SFN is connected with upregulation of p38 MAP kinase and caspase -7 activation in MCF-7 cells [32], global changes in gene expression [33] or downregulation of ER, EGFR or HER2 mRNAs [16, 34].